S-ICDs: advantages and opportunities for improvement

References

• Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980 Aug 7;303(6):322–324.
   PubMed Web of Science ®Google Scholar
• Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007 May 15;115(19):2474–2480.
   PubMed Web of Science ®Google Scholar
• Cohen MC, Rohtla KM, Lavery CE, et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997;79(11):1512–1516.
   PubMed Web of Science ®Google Scholar
• Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010 Jul 1;363(1):36–44.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by. Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015 Nov 2015; 17 (11). 1601–1687.
   Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2017 [2018 Oct];15(10):e190–e252.
   PubMed Web of Science ®Google Scholar
• Statistiques 2020. Statistiques des DAI en français. [cited 2021 Dec 04]. Available from: http://www.rhythmologie-stiftung.ch/statistiken_fr.html
   Google Scholar
• Gold MR, Lambiase PD, El-Chami MF, et al. Primary results from the understanding outcomes with the s-icd in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation. 2021 Jan 5;143(1):7–17.
   PubMed Web of Science ®Google Scholar
• Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and effortless registry. J Am Coll Cardiol. 2015 Apr 28;65(16):1605–1615.
   PubMed Web of Science ®Google Scholar
• Stiles MK, Fauchier L, Morillo CA, et al. HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2019 [2019 Sep 1];21(9):1442–1443.
   PubMed Web of Science ®Google Scholar
• Lambiase PD, Theuns DA, Murgatroyd F, et al. Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J. 2022 Jan 28; 10.1093/eurheartj/ehab921
   Google Scholar
• Knops RE, van der Stuijt W, Delnoy P, et al. Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial. Circulation. 2022 Feb;145(5):321–329.
   PubMed Web of Science ®Google Scholar
• Ollitrault P, Jacon P, Auquier N, et al. Atrial fibrillation detection by the subcutaneous defibrillator: real-world clinical performances and implications from a multicentre study. Europace. 2020 Nov 1;22(11):1628–1634.
   PubMed Web of Science ®Google Scholar
• Baalman SWE, Mittal S, Boersma LVA, et al. Real-world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD. Pacing Clin Electrophysiol. 2020 Dec;43(12):1467–1475.
   PubMed Web of Science ®Google Scholar
• Kutyifa V, Rosero SZ, McNitt S, et al. Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: clinical implications for the subcutaneous ICD. Ann Noninvasive Electrocardiol. 2020 Jul;25(4):e12744.
   PubMed Web of Science ®Google Scholar
• Zeitler EP, Friedman DJ, Loring Z, et al. Complications involving the subcutaneous implantable cardioverter-defibrillator: lessons learned from MAUDE. Heart Rhythm. 2020 Mar;17(3):447–454.
   PubMed Web of Science ®Google Scholar
• Arias MA, Pachon M, Sanchez-Iglesias I, et al. Impact of routine right parasternal electrocardiographic screening in assessing eligibility for subcutaneous implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2020 Jan;31(1):103–111.
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LRA, Warnaars JLF, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014 May;25(5):494–499.
   PubMed Web of Science ®Google Scholar
• Randles DA, Hawkins NM, Shaw M, et al. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014 Jul;16(7):1015–1021.
   PubMed Web of Science ®Google Scholar
• Conte G, Cattaneo F, de Asmundis C, et al. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study. Europace. 2021 Sep 9. 10.1093/europace/euab230.
   Google Scholar
• Silvetti MS, Pazzano V, Verticelli L, et al. Subcutaneous implantable cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study. Europace. 2018 Dec 1;20(12):1966–1973.
   PubMed Web of Science ®Google Scholar
• von Alvensleben JC, Dechert B, Bradley DJ, et al. Subcutaneous implantable cardioverter-defibrillators in pediatrics and congenital heart disease: a pediatric and congenital electrophysiology society multicenter review. JACC Clin Electrophysiol. 2020 Dec;6(14):1752–1761.
   PubMedGoogle Scholar
• Kobe J, Reinke F, Meyer C, et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm. 2013 Jan;10(1):29–36.
   PubMed Web of Science ®Google Scholar
• Knops RE, Olde Nordkamp LR, de Groot JR, et al. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013 Aug;10(8):1240–1243.
   PubMed Web of Science ®Google Scholar
• Quast ABE, Baalman SWE, Brouwer TF, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm. 2019 Mar;16(3):403–410.
   PubMed Web of Science ®Google Scholar
• El-Chami M, Weiss R, Burke MC, et al. Outcomes of two versus three incision techniques: results from the subcutaneous ICD post-approval study. J Cardiovasc Electrophysiol. 2021 Mar;32(3):792–801.
   PubMed Web of Science ®Google Scholar
• Knops RE, Brouwer TF, Barr CS, et al. The learning curve associated with the introduction of the subcutaneous implantable defibrillator. Europace. 2016 Jul;18(7):1010–1015.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Fauchier L, Stiles MK, et al. HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2015 [2016 Feb];13(2):e50–86.
   PubMed Web of Science ®Google Scholar
• Elders J, AlHashimi H. Left-sided humerus fracture as an unusual complication of defibrillation threshold testing following S-ICD implantation. JACC Case Rep. 2020 Feb;2(2): 255–257.
   PubMedGoogle Scholar
• le Polain de Waroux JB, Ploux S, Mondoly P, et al. Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. Heart Rhythm. 2018 May;15(5):642–650.
   PubMed Web of Science ®Google Scholar
• Tamura S, Yoshiyama T, Doi A, et al. Absence of shock therapy related to improper sensing of noise on the defibrillation test during subcutaneous implantable cardioverter-defibrillator implantation: a case report. Eur Heart J Case Rep. 2020 Dec;4(6):1–6.
   Google Scholar
• Baalman SWE, Kooiman KM, Quast ABE, et al. Noise caused by involuntary muscle response may inhibit detection of ventricular fibrillation during defibrillation testing. HeartRhythm Case Rep. 2020 Mar;6(3):126–130.
   PubMedGoogle Scholar
• Miller MA, Palaniswamy C, Dukkipati SR, et al. Subcutaneous Implantable Cardioverter-Defibrillator Implantation without defibrillation testing. J Am Coll Cardiol. 2017 Jun 27;69(25):3118–3119.
   PubMed Web of Science ®Google Scholar
• Ricciardi D, Ziacchi M, Gasperetti A, et al. Clinical impact of defibrillation testing in a real-world S-ICD population: data from the ELISIR registry. J Cardiovasc Electrophysiol. 2021 Feb;32(2):468–476.
   PubMed Web of Science ®Google Scholar
• Rudic B, Tulumen E, Fastenrath F, et al. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator. Heart Rhythm. 2020 Mar;17(3):455–459.
   PubMed Web of Science ®Google Scholar
• Li JM, Li Y, Tholakanahalli V, et al. Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator. HeartRhythm Case Rep. 2020 Mar;6(3):148–152.
   PubMedGoogle Scholar
• Aydin A, Hartel F, Schluter M, et al. Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol. 2012 Oct;5(5):913–919.
   PubMed Web of Science ®Google Scholar
• Dabiri Abkenari L, Theuns DA, Valk SD, et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol. 2011 Sep;100(9):737–744.
   PubMed Web of Science ®Google Scholar
• Jarman JW, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J. 2012 Jun;33(11):1351–1359.
   PubMed Web of Science ®Google Scholar
• Lambiase PD, Barr C, Theuns DA, et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J. 2014 Jul 1;35(25):1657–1665.
   PubMed Web of Science ®Google Scholar
• Knops RE, Olde Nordkamp LRA, Delnoy PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020 Aug 6;383(6):526–536.
   PubMed Web of Science ®Google Scholar
• Mandrola J, Enache B, Redberg RF. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med. 2021 Feb 18;384(7):676–677.
   PubMedGoogle Scholar
• Auricchio A, Schloss EJ, Kurita T, et al. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: painFree SST trial primary results. Heart Rhythm. 2015 May;12(5):926–936.
   PubMed Web of Science ®Google Scholar
• Kooiman KM, Knops RE, Olde Nordkamp L, et al. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm. 2014 Mar;11(3):426–434.
   PubMed Web of Science ®Google Scholar
• Behar N, Galand V, Martins RP, et al. Subcutaneous implantable cardioverter-defibrillator lead extraction: first multicenter French experience. JACC Clin Electrophysiol. 2020 Jul;6(7):863–870.
   PubMedGoogle Scholar
• Mitacchione G, Schiavone M, Gasperetti A, et al. Neglected lead tip erosion: an unusual case of S-ICD inappropriate shock. J Cardiovasc Electrophysiol. 2020 Dec;31(12):3322–3325.
   PubMed Web of Science ®Google Scholar
• Gasperetti A, Schiavone M, Ziacchi M, et al. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience. Heart Rhythm. 2021 Dec;18(12):2050–2058.
   PubMed Web of Science ®Google Scholar
• van der Stuijt W, Quast ABE, Baalman SWE, et al. Improving the care for female subcutaneous ICD patients: a qualitative study of gender-specific issues. Int J Cardiol. 2020 Oct 15;317:91–95.
   PubMed Web of Science ®Google Scholar
• Tjong FVY, Koop BE. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD. Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):355–361.
   PubMedGoogle Scholar
• Gauthey A, Calle S, Accinelli S, et al. His bundle pacing for newly acquired pacing needs in patients implanted with a subcutaneous implantable cardioverter defibrillator: a feasibility study based on the automated screening score and clinical cases. J Cardiovasc Electrophysiol. 2020 Jul;31(7):1793–1800.
   PubMed Web of Science ®Google Scholar
• Chan JYS, Lelakowski J, Murgatroyd FD, et al. Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol. 2017 Aug;3(8):905–910.
   PubMedGoogle Scholar
• Crozier I, Haqqani H, Kotschet E, et al. First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator. JACC Clin Electrophysiol. 2020 Nov;6(12):1525–1536.
   PubMedGoogle Scholar
• Crozier I, O’Donnell D, Boersma L, et al. The extravascular implantable cardioverter-defibrillator: the pivotal study plan. J Cardiovasc Electrophysiol. 2021 Sep;32(9):2371–2378.
   PubMed Web of Science ®Google Scholar
• Oosterwerff EFJ, Salavati A, Lenssen M, et al. Experience with malfunctioning leadless pacemakers: troubleshooting and management during medium term follow-up. Heart Rhythm. 2022 Jan 25. DOI:10.1016/j.hrthm.2022.01.028.
   PubMed Web of Science ®Google Scholar
• Valiton V, Graf D, Pruvot E, et al. Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region. Europace. 2019 Feb 1;21(2):275–280.
   PubMedGoogle Scholar
• Crossley G, Sanders P, De Filippo P, et al. Rationale and design of the lead evaluation for defibrillation and reliability (leadr) study: safety and efficacy of a novel icd lead design. 10.22541/au.164079993.30387844/v1.
   Google Scholar